| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ADMA BIOLOGICS, INC. | Director | Common Stock | 2.03M | $44.1M | $21.69 | Jun 12, 2025 | Indirect |
| ADMA BIOLOGICS, INC. | Director | Common Stock | 87.3K | $1.77M | $20.24 | Jun 16, 2025 | Direct |
| Marker Therapeutics, Inc. | Director | Common Stock | 325K | $1.04M | $3.20 | Dec 23, 2024 | Indirect |
| ADMA BIOLOGICS, INC. | Director | Stock Option (Right to Buy) | 0 | $59.6K | $3.66 | Jun 13, 2025 | Direct |
| Marker Therapeutics, Inc. | Director | Common Stock | 2.97K | $9.5K | $3.20 | Dec 23, 2024 | Direct |
| Zosano Pharma Corp | Director | Common Stock | 2.72M | Jun 10, 2021 | (2) | ||
| Marker Therapeutics, Inc. | Director | Stock Option (right to buy) | 30K | Feb 12, 2025 | Direct | ||
| Zosano Pharma Corp | Director | Stock Option (Right to Buy) | 30K | Jun 10, 2021 | Direct | ||
| Zosano Pharma Corp | Director | Common Stock | 22.5K | Jun 10, 2021 | Direct | ||
| Elevation Oncology, Inc. | Director | Stock Option (Right to Buy) | 0 | Jul 23, 2025 | Indirect |